IVD Reagents Market by Type (Antibodies, Nucleic Acid Probes), technology (Hematology), Application (Genetic Testing, Autoimmune disease), Test Type (Laboratory Test, Point-of-care Tests), End User (Hospitals & Clinics) & Region - Global Forecast to 2029

IVD Reagents Market by Type (Antibodies, Nucleic Acid Probes), technology (Hematology), Application (Genetic Testing, Autoimmune disease), Test Type (Laboratory Test, Point-of-care Tests), End User (Hospitals & Clinics) & Region - Global Forecast to 2029

The global IVD reagents market is valued at an estimated 87.41 billion in 2029 and is projected to reach USD 60.45 billion by 2024, at a CAGR of 7.7% during the forecast period. The increasing adoption of IVD technologies has led to a growing need of IVD reagents. The demand for IVD reagents is therefore expected to increase as new diagnostic technologies are getting FDA, EMA approvals from regulatory bodies.

“The oligonucleotide segment is projected to witness the highest growth rate in the IVD reagents market, by type, during the forecast period.”

Based on type, the IVD reagents market is segmented into antibodies, antigen, purified proteins, and peptides, oligonucleotides, nucleic acid probes, and other IVD reagents. The growing adoption of PCR-based tests in diagnostics has boosted the demand for oligonucleotide in the IVD reagents market. Oligonucleotides have wide range of applications in infectious diseases and genetic testing.

“The infectious disease segment to witness the highest share in the IVD reagents market, in 2023, by application”

Based on application, the IVD reagents market is segmented into infectious diseases, oncological applications, endocrinological applications, cardiological applications, blood screening, genetic testing, autoimmune diseases, allergy diagnostics, drug monitoring & testing and other applications. The infectious diseases segment experience highest market share of IVD reagents market due to rising number of R&D activities and product approvals for infectious disease applications.

“The Asia Pacific region is projected to witness highest growth rate in the IVD reagents market during the forecast period”

The global IVD reagents market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the IVD reagents market is expected to grow at the fastest rate in the Asia Pacific region. Over the projected period, the Asia Pacific market is expected to develop at the greatest rate due to factors such increasing healthcare spending and an extensive population base.

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 - 42%, Tier 2 - 30%, and Tier 3 - 28%

By Designation: C-level - 46%, Director-level - 23%, and Others - 31%

By Region: North America – 23%, Europe – 44%, Asia Pacific – 28%, Latin America – 3%, Middle East & Africa – 1%, and the GCC Countries – 1%

Lists of Companies Profiled in the Report:

Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), BioMerieux (France), BD (US), Hologic, Inc. (US), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), Revvity (US), DiaSorin S.p.A (Italy), Grifols, S.A. (Spain), Werfen, S.A. (Spain), QuidelOrtho Corporation (US), Chembio Diagnostics, Inc. (US), Surmodics, Inc. (US), Merck KGaA (Germany), MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. (Tokyo), Canvax (Spain), Prestige Diagnostics (US), Adaltis S.r.l. (Italy), and Randox Laboratories Ltd. (UK)

Study Coverage:

In this report, the IVD reagents market has been categorized based on type (antibodies, antigen, purified proteins, and peptides, oligonucleotides, nucleic acid probes, and other IVD reagents), technology (immunoassays, clinical chemistry, molecular diagnostics, hematology, microbiology, coagulation & hemostasis, urinalysis, chromatography & mass spectrometry, immunohistochemistry), application (infectious diseases, oncological applications, endocrinological application, cardiology application, blood screening, genetic testing, autoimmune diseases, allergy diagnostics, drug monitoring & testing, and other applications), test type (laboratory test, and point-of-care tests), end user (hospitals & clinics, clinical laboratories, blood banks, home care settings, pharmaceutical & biotechnology companies, academic institutes, and other end users), and region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and the GCC Countries).

Information regarding the main drivers, restraints, opportunities, and challenges influencing the IVD reagents market's expansion is includes detail in this study. An intensive study of the key players in the IVD reagents market has been done to provide insights into their business profile, service offered, note worthy strategies, acquisitions and expansions, and other deals made pertaining to the market. This study examines the fragmented landscape of emerging IVD reagents startups.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall IVD reagents marketand the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, opportunities, and restaints.

The report provides insights on the following pointers:

Analysis of key drivers: (growing geriatric population, gradual shift towards point-of-care testing and automated analyzers, rise in early diagnosis and personalized medicine, increasing adoption of third-party quality controls, growing biotechnology and biopharmaceutical industries, increasing funding for R&D activities), restraints (unfavorable reimbursement scenario, stringent regulatory requirements), opportunities (increasing development of biomarkers, rising significance of companion diagnostics, market growth opportunities in emerging economies, and growing trend of digitalization), and challenges (operational challenges in clinical process) influencing the growth of the in IVD reagents market.

Market Development: Comprehensive information about lucrative markets – the report analyses the IVD reagents market across varied regions.

Market Diversification: Exhaustive information about untapped geographies, and investments in the IVD reagents market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like include F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Danaher Corporation (US), Siemens Healthineers AG (Germany), and Thermo Fisher Scientific Inc. (US) are among others, in the IVD reagents market strategies.

Tables List

Table 1 Ivd Reagents Market: Inclusions And Exclusions

Table 2 Ivd Reagents Market: Risk Assessment

Table 3 Estimated Increase In Geriatric Population, By Region, 2022 Vs. 2030 Vs. 2050

Table 4 Recent Developments In Ivd Reagents Market In Emerging Economies,

2022–2023

Table 5 Average Selling Price Trend Of Key Players For Top 2 Applications,

2021–2023 (Usd)

Table 6 Average Selling Price Trend Of Key Players, By Region, 2021–2023 (Usd)

Table 7 Average Selling Price Trend, By Technology, 2021–2023 (Usd)

Table 8 Ivd Reagents Market: Role Of Companies In Ecosystem

Table 9 Ivd Reagents Market: Key Technologies

Table 10 Import Data For Hs Code 382200, By Country, 2019–2023 (Usd Million)

Table 11 Export Data For Hs Code 382200, By Country, 2019–2023 (Usd Million)

Table 12 Ivd Reagents Market: Key Conferences And Events, 2024−2025

Table 13 Ivd Reagents Market: Porter’s Five Forces Analysis

Table 14 Us: Classification Of Quality Control Material For Ivd Reagents

Table 15 Us: Time, Cost, And Complexity Of Registration For Ivd Reagents

Table 16 Canada: Classification Of Ivd Products

Table 17 Canada: Time, Cost, And Complexity Of Registration For Ivd Reagents

Table 18 Europe: Accreditation Bodies For Medical Laboratories

Table 19 Europe: Classification Of Ivd Reagents

Table 20 Europe: Time, Cost, And Complexity Of Registration For Ivd Reagents

Table 21 China: Time, Cost, And Complexity Of Registration For Ivd Reagents

Table 22 Japan: Classification Of Ivd Reagents

Table 23 Japan: Time, Cost, And Complexity Of Registration For Ivd Reagents

Table 24 North America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 25 Europe: Regulatory Bodies, Government Agencies, And Other Organizations

Table 26 Asia Pacific: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 27 Latin America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 28 Middle East & Africa: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 29 Gcc Countries: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 30 Influence Of Stakeholders On Buying Process Of Ivd Reagents,

By End User (%)

Table 31 Key Buying Criteria For Ivd Reagents, By End User

Table 32 Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 33 Companies Providing Antibodies

Table 34 Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 35 Antibodies Market, By Region, 2022–2029 (Usd Million)

Table 36 North America: Antibodies Market, By Country, 2022–2029 (Usd Million)

Table 37 Europe: Antibodies Market, By Country, 2022–2029 (Usd Million)

Table 38 Asia Pacific: Antibodies Market, By Country, 2022–2029 (Usd Million)

Table 39 Latin America: Antibodies Market, By Country, 2022–2029 (Usd Million)

Table 40 Gcc Countries: Antibodies Market, By Country, 2022–2029 (Usd Million)

Table 41 Monoclonal Antibodies Market, By Region, 2022–2029 (Usd Million)

Table 42 North America: Monoclonal Antibodies Market,

By Country, 2022–2029 (Usd Million)

Table 43 Europe: Monoclonal Antibodies Market, By Country, 2022–2029 (Usd Million)

Table 44 Asia Pacific: Monoclonal Antibodies Market,

By Country, 2022–2029 (Usd Million)

Table 45 Latin America: Monoclonal Antibodies Market,

By Country, 2022–2029 (Usd Million)

Table 46 Gcc Countries: Monoclonal Antibodies Market,

By Country, 2022–2029 (Usd Million)

Table 47 Polyclonal Antibodies Market, By Region, 2022–2029 (Usd Million)

Table 48 North America: Polyclonal Antibodies Market,

By Country, 2022–2029 (Usd Million)

Table 49 Europe: Polyclonal Antibodies Market, By Country, 2022–2029 (Usd Million)

Table 50 Asia Pacific: Polyclonal Antibodies Market,

By Country, 2022–2029 (Usd Million)

Table 51 Latin America: Polyclonal Antibodies Market,

By Country, 2022–2029 (Usd Million)

Table 52 Gcc Countries: Polyclonal Antibodies Market,

By Country, 2022–2029 (Usd Million)

Table 53 Companies Providing Antigens, Purified Proteins, And Peptides

Table 54 Antigens, Purified Proteins, And Peptides Market,

By Region, 2022–2029 (Usd Million)

Table 55 North America: Antigens, Purified Proteins, And Peptides Market,

By Country, 2022–2029 (Usd Million)

Table 56 Europe: Antigens, Purified Proteins, And Peptides Market,

By Country, 2022–2029 (Usd Million)

Table 57 Asia Pacific: Antigens, Purified Proteins, And Peptides Market,

By Country, 2022–2029 (Usd Million)

Table 58 Latin America: Antigens, Purified Proteins, And Peptides Market,

By Country, 2022–2029 (Usd Million)

Table 59 Gcc Countries: Antigens, Purified Proteins, And Peptides Market,

By Country, 2022–2029 (Usd Million)

Table 60 Companies Providing Oligonucleotides

Table 61 Oligonucleotides Market, By Region, 2022–2029 (Usd Million)

Table 62 North America: Oligonucleotides Market,

By Country, 2022–2029 (Usd Million)

Table 63 Europe: Oligonucleotides Market, By Country, 2022–2029 (Usd Million)

Table 64 Asia Pacific: Oligonucleotides Market, By Country, 2022–2029 (Usd Million)

Table 65 Latin America: Oligonucleotides Market, By Country, 2022–2029 (Usd Million)

Table 66 Gcc Countries: Oligonucleotides Market,

By Country, 2022–2029 (Usd Million)

Table 67 Companies Providing Nucleic Acid Probes

Table 68 Nucleic Acid Probes Market, By Region, 2022–2029 (Usd Million)

Table 69 North America: Nucleic Acid Probes Market, By Country,

2022–2029 (Usd Million)

Table 70 Europe: Nucleic Acid Probes Market, By Country, 2022–2029 (Usd Million)

Table 71 Asia Pacific: Nucleic Acid Probes Market, By Country, 2022–2029 (Usd Million)

Table 72 Latin America: Nucleic Acid Probes Market,

By Country, 2022–2029 (Usd Million)

Table 73 Gcc Countries: Nucleic Acid Probes Market,

By Country, 2022–2029 (Usd Million)

Table 74 Companies Providing Other Ivd Reagents

Table 75 Other Ivd Reagents Market, By Region, 2022–2029 (Usd Million)

Table 76 North America: Other Ivd Reagents Market,

By Country, 2022–2029 (Usd Million)

Table 77 Europe: Other Ivd Reagents Market, By Country, 2022–2029 (Usd Million)

Table 78 Asia Pacific: Other Ivd Reagents Market, By Country, 2022–2029 (Usd Million)

Table 79 Latin America: Other Ivd Reagents Market,

By Country, 2022–2029 (Usd Million)

Table 80 Gcc Countries: Other Ivd Reagents Market,

By Country, 2022–2029 (Usd Million)

Table 81 Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 82 Ivd Reagents Market For Immunoassays, By Region, 2022–2029 (Usd Million)

Table 83 North America: Ivd Reagents Market For Immunoassays,

By Country, 2022–2029 (Usd Million)

Table 84 Europe: Ivd Reagents Market For Immunoassays,

By Country, 2022–2029 (Usd Million)

Table 85 Asia Pacific: Ivd Reagents Market For Immunoassays,

By Country, 2022–2029 (Usd Million)

Table 86 Latin America: Ivd Reagents Market For Immunoassays,

By Country, 2022–2029 (Usd Million)

Table 87 Gcc Countries: Ivd Reagents Market For Immunoassays,

By Country, 2022–2029 (Usd Million)

Table 88 Ivd Reagents Market For Clinical Chemistry,

By Region, 2022–2029 (Usd Million)

Table 89 North America: Ivd Reagents Market For Clinical Chemistry,

By Country, 2022–2029 (Usd Million)

Table 90 Europe: Ivd Reagents Market For Clinical Chemistry,

By Country, 2022–2029 (Usd Million)

Table 91 Asia Pacific: Ivd Reagents Market For Clinical Chemistry,

By Country, 2022–2029 (Usd Million)

Table 92 Latin America: Ivd Reagents Market For Clinical Chemistry,

By Country, 2022–2029 (Usd Million)

Table 93 Gcc Countries: Ivd Reagents Market For Clinical Chemistry,

By Country, 2022–2029 (Usd Million)

Table 94 Ivd Reagents Market For Molecular Diagnostics,

By Region, 2022–2029 (Usd Million)

Table 95 North America: Ivd Reagents Market For Molecular Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 96 Europe: Ivd Reagents Market For Molecular Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 97 Asia Pacific: Ivd Reagents Market For Molecular Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 98 Latin America: Ivd Reagents Market For Molecular Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 99 Gcc Countries: Ivd Reagents Market For Molecular Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 100 Ivd Reagents Market For Hematology, By Region, 2022–2029 (Usd Million)

Table 101 North America: Ivd Reagents Market For Hematology,

By Country, 2022–2029 (Usd Million)

Table 102 Europe: Ivd Reagents Market For Hematology,

By Country, 2022–2029 (Usd Million)

Table 103 Asia Pacific: Ivd Reagents Market For Hematology,

By Country, 2022–2029 (Usd Million)

Table 104 Latin America: Ivd Reagents Market For Hematology,

By Country, 2022–2029 (Usd Million)

Table 105 Gcc Countries: Ivd Reagents Market For Hematology,

By Country, 2022–2029 (Usd Million)

Table 106 Ivd Reagents Market For Microbiology, By Region, 2022–2029 (Usd Million)

Table 107 North America: Ivd Reagents Market For Microbiology,

By Country, 2022–2029 (Usd Million)

Table 108 Europe: Ivd Reagents Market For Microbiology,

By Country, 2022–2029 (Usd Million)

Table 109 Asia Pacific: Ivd Reagents Market For Microbiology,

By Country, 2022–2029 (Usd Million)

Table 110 Latin America: Ivd Reagents Market For Microbiology,

By Country, 2022–2029 (Usd Million)

Table 111 Gcc Countries: Ivd Reagents Market For Microbiology,

By Country, 2022–2029 (Usd Million)

Table 112 Ivd Reagents Market For Coagulation & Hemostasis,

By Region, 2022–2029 (Usd Million)

Table 113 North America: Ivd Reagents Market For Coagulation & Hemostasis,

By Country, 2022–2029 (Usd Million)

Table 114 Europe: Ivd Reagents Market For Coagulation & Hemostasis,

By Country, 2022–2029 (Usd Million)

Table 115 Asia Pacific: Ivd Reagents Market For Coagulation & Hemostasis,

By Country, 2022–2029 (Usd Million)

Table 116 Latin America: Ivd Reagents Market For Coagulation & Hemostasis,

By Country, 2022–2029 (Usd Million)

Table 117 Gcc Countries: Ivd Reagents Market For Coagulation & Hemostasis,

By Country, 2022–2029 (Usd Million)

Table 118 Ivd Reagents Market For Urinalysis, By Region, 2022–2029 (Usd Million)

Table 119 North America: Ivd Reagents Market For Urinalysis,

By Country, 2022–2029 (Usd Million)

Table 120 Europe: Ivd Reagents Market For Urinalysis,

By Country, 2022–2029 (Usd Million)

Table 121 Asia Pacific: Ivd Reagents Market For Urinalysis,

By Country, 2022–2029 (Usd Million)

Table 122 Latin America: Ivd Reagents Market For Urinalysis,

By Country, 2022–2029 (Usd Million)

Table 123 Gcc Countries: Ivd Reagents Market For Urinalysis,

By Country, 2022–2029 (Usd Million)

Table 124 Ivd Reagents Market For Chromatography & Mass Spectrometry,

By Region, 2022–2029 (Usd Million)

Table 125 North America: Ivd Reagents Market For Chromatography &

Mass Spectrometry, By Country, 2022–2029 (Usd Million)

Table 126 Europe: Ivd Reagents Market For Chromatography & Mass Spectrometry,

By Country, 2022–2029 (Usd Million)

Table 127 Asia Pacific: Ivd Reagents Market For Chromatography &

Mass Spectrometry, By Country, 2022–2029 (Usd Million)

Table 128 Latin America: Ivd Reagents Market For Chromatography

& Mass Spectrometry, By Country, 2022–2029 (Usd Million)

Table 129 Gcc Countries: Ivd Reagents Market For Chromatography

& Mass Spectrometry, By Country, 2022–2029 (Usd Million)

Table 130 Ivd Reagents Market For Immunohistochemistry,

By Region, 2022–2029 (Usd Million)

Table 131 North America: Ivd Reagents Market For Immunohistochemistry,

By Country, 2022–2029 (Usd Million)

Table 132 Europe: Ivd Reagents Market For Immunohistochemistry,

By Country, 2022–2029 (Usd Million)

Table 133 Asia Pacific: Ivd Reagents Market For Immunohistochemistry,

By Country, 2022–2029 (Usd Million)

Table 134 Latin America: Ivd Reagents Market For Immunohistochemistry,

By Country, 2022–2029 (Usd Million)

Table 135 Gcc Countries: Ivd Reagents Market For Immunohistochemistry,

By Country, 2022–2029 (Usd Million)

Table 136 Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 137 Ivd Reagents Market For Infectious Diseases,

By Region, 2022–2029 (Usd Million)

Table 138 North America: Ivd Reagents Market For Infectious Diseases,

By Country, 2022–2029 (Usd Million)

Table 139 Europe: Ivd Reagents Market For Infectious Diseases,

By Country, 2022–2029 (Usd Million)

Table 140 Asia Pacific: Ivd Reagents Market For Infectious Diseases,

By Country, 2022–2029 (Usd Million)

Table 141 Latin America: Ivd Reagents Market For Infectious Diseases,

By Country, 2022–2029 (Usd Million)

Table 142 Gcc Countries: Ivd Reagents Market For Infectious Diseases,

By Country, 2022–2029 (Usd Million)

Table 143 Estimated Number Of New Cases Of Cancer For 0–85+ Years Of Age,

2022 Vs. 2030

Table 144 Ivd Reagents Market For Oncological Applications,

By Region, 2022–2029 (Usd Million)

Table 145 North America: Ivd Reagents Market For Oncological Applications,

By Country, 2022–2029 (Usd Million)

Table 146 Europe: Ivd Reagents Market For Oncological Applications,

By Country, 2022–2029 (Usd Million)

Table 147 Asia Pacific: Ivd Reagents Market For Oncological Applications,

By Country, 2022–2029 (Usd Million)

Table 148 Latin America: Ivd Reagents Market For Oncological Applications,

By Country, 2022–2029 (Usd Million)

Table 149 Gcc Countries: Ivd Reagents Market For Oncological Applications,

By Country, 2022–2029 (Usd Million)

Table 150 Ivd Reagents Market For Endocrinological Applications,

By Region, 2022–2029 (Usd Million)

Table 151 North America: Ivd Reagents Market For Endocrinological Applications,

By Country, 2022–2029 (Usd Million)

Table 152 Europe: Ivd Reagents Market For Endocrinological Applications,

By Country, 2022–2029 (Usd Million)

Table 153 Asia Pacific: Ivd Reagents Market For Endocrinological Applications,

By Country, 2022–2029 (Usd Million)

Table 154 Latin America: Ivd Reagents Market For Endocrinological Applications,

By Country, 2022–2029 (Usd Million)

Table 155 Gcc Countries: Ivd Reagents Market For Endocrinological Applications,

By Country, 2022–2029 (Usd Million)

Table 156 Ivd Reagents Market For Cardiological Applications,

By Region, 2022–2029 (Usd Million)

Table 157 North America: Ivd Reagents Market For Cardiological Applications,

By Country, 2022–2029 (Usd Million)

Table 158 Europe: Ivd Reagents Market For Cardiological Applications,

By Country, 2022–2029 (Usd Million)

Table 159 Asia Pacific: Ivd Reagents Market For Cardiological Applications,

By Country, 2022–2029 (Usd Million)

Table 160 Latin America: Ivd Reagents Market For Cardiological Applications,

By Country, 2022–2029 (Usd Million)

Table 161 Gcc Countries: Ivd Reagents Market For Cardiological Applications,

By Country, 2022–2029 (Usd Million)

Table 162 Ivd Reagents Market For Blood Screening,

By Region, 2022–2029 (Usd Million)

Table 163 North America: Ivd Reagents Market For Blood Screening,

By Country, 2022–2029 (Usd Million)

Table 164 Europe: Ivd Reagents Market For Blood Screening,

By Country, 2022–2029 (Usd Million)

Table 165 Asia Pacific: Ivd Reagents Market For Blood Screening,

By Country, 2022–2029 (Usd Million)

Table 166 Latin America: Ivd Reagents Market For Blood Screening,

By Country, 2022–2029 (Usd Million)

Table 167 Gcc Countries: Ivd Reagents Market For Blood Screening,

By Country, 2022–2029 (Usd Million)

Table 168 Ivd Reagents Market For Genetic Testing, By Region, 2022–2029 (Usd Million)

Table 169 North America: Ivd Reagents Market For Genetic Testing,

By Country, 2022–2029 (Usd Million)

Table 170 Europe: Ivd Reagents Market For Genetic Testing,

By Country, 2022–2029 (Usd Million)

Table 171 Asia Pacific: Ivd Reagents Market For Genetic Testing,

By Country, 2022–2029 (Usd Million)

Table 172 Latin America: Ivd Reagents Market For Genetic Testing,

By Country, 2022–2029 (Usd Million)

Table 173 Gcc Countries: Ivd Reagents Market For Genetic Testing,

By Country, 2022–2029 (Usd Million)

Table 174 Ivd Reagents Market For Autoimmune Diseases,

By Region, 2022–2029 (Usd Million)

Table 175 North America: Ivd Reagents Market For Autoimmune Diseases,

By Country, 2022–2029 (Usd Million)

Table 176 Europe: Ivd Reagents Market For Autoimmune Diseases,

By Country, 2022–2029 (Usd Million)

Table 177 Asia Pacific: Ivd Reagents Market For Autoimmune Diseases,

By Country, 2022–2029 (Usd Million)

Table 178 Latin America: Ivd Reagents Market For Autoimmune Diseases,

By Country, 2022–2029 (Usd Million)

Table 179 Gcc Countries: Ivd Reagents Market For Autoimmune Diseases,

By Country, 2022–2029 (Usd Million)

Table 180 Ivd Reagents Market For Allergy Diagnostics,

By Region, 2022–2029 (Usd Million)

Table 181 North America: Ivd Reagents Market For Allergy Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 182 Europe: Ivd Reagents Market For Allergy Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 183 Asia Pacific: Ivd Reagents Market For Allergy Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 184 Latin America: Ivd Reagents Market For Allergy Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 185 Gcc Countries: Ivd Reagents Market For Allergy Diagnostics,

By Country, 2022–2029 (Usd Million)

Table 186 Key Products For Drug Monitoring

Table 187 Ivd Reagents Market For Drug Monitoring & Testing,

By Region, 2022–2029 (Usd Million)

Table 188 North America: Ivd Reagents Market For Drug Monitoring & Testing,

By Country, 2022–2029 (Usd Million)

Table 189 Europe: Ivd Reagents Market For Drug Monitoring & Testing,

By Country, 2022–2029 (Usd Million)

Table 190 Asia Pacific: Ivd Reagents Market For Drug Monitoring & Testing,

By Country, 2022–2029 (Usd Million)

Table 191 Latin America: Ivd Reagents Market For Drug Monitoring & Testing,

By Country, 2022–2029 (Usd Million)

Table 192 Gcc Countries: Ivd Reagents Market For Drug Monitoring & Testing,

By Country, 2022–2029 (Usd Million)

Table 193 Ivd Reagents Market For Other Applications,

By Region, 2022–2029 (Usd Million)

Table 194 North America: Ivd Reagents Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 195 Europe: Ivd Reagents Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 196 Asia Pacific: Ivd Reagents Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 197 Latin America: Ivd Reagents Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 198 Gcc Countries: Ivd Reagents Market For Other Applications,

By Country, 2022–2029 (Usd Million)

Table 199 Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 200 Ivd Reagents Market For Laboratory Tests,

By Region, 2022–2029 (Usd Million)

Table 201 North America: Ivd Reagents Market For Laboratory Tests,

By Country, 2022–2029 (Usd Million)

Table 202 Europe: Ivd Reagents Market For Laboratory Tests,

By Country, 2022–2029 (Usd Million)

Table 203 Asia Pacific: Ivd Reagents Market For Laboratory Tests,

By Country, 2022–2029 (Usd Million)

Table 204 Latin America: Ivd Reagents Market For Laboratory Tests,

By Country, 2022–2029 (Usd Million)

Table 205 Gcc Countries: Ivd Reagents Market For Laboratory Tests,

By Country, 2022–2029 (Usd Million)

Table 206 Ivd Reagents Market For Point-of-care Tests,

By Region, 2022–2029 (Usd Million)

Table 207 North America: Ivd Reagents Market For Point-of-care Tests,

By Country, 2022–2029 (Usd Million)

Table 208 Europe: Ivd Reagents Market For Point-of-care Tests,

By Country, 2022–2029 (Usd Million)

Table 209 Asia Pacific: Ivd Reagents Market For Point-of-care Tests,

By Country, 2022–2029 (Usd Million)

Table 210 Latin America: Ivd Reagents Market For Point-of-care Tests,

By Country, 2022–2029 (Usd Million)

Table 211 Gcc Countries: Ivd Reagents Market For Point-of-care Tests,

By Country, 2022–2029 (Usd Million)

Table 212 Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 213 Ivd Reagents Market For Hospitals & Clinics,

By Region, 2022–2029 (Usd Million)

Table 214 North America: Ivd Reagents Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 215 Europe: Ivd Reagents Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 216 Asia Pacific: Ivd Reagents Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 217 Latin America: Ivd Reagents Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 218 Gcc Countries: Ivd Reagents Market For Hospitals & Clinics,

By Country, 2022–2029 (Usd Million)

Table 219 Ivd Reagents Market For Clinical Laboratories,

By Region, 2022–2029 (Usd Million)

Table 220 Ivd Reagents Market For Clinical Laboratories,

By Type, 2022–2029 (Usd Million)

Table 221 North America: Ivd Reagents Market For Clinical Laboratories,

By Country, 2022–2029 (Usd Million)

Table 222 Europe: Ivd Reagents Market For Clinical Laboratories,

By Country, 2022–2029 (Usd Million)

Table 223 Asia Pacific: Ivd Reagents Market For Clinical Laboratories,

By Country, 2022–2029 (Usd Million)

Table 224 Latin America: Ivd Reagents Market For Clinical Laboratories,

By Country, 2022–2029 (Usd Million)

Table 225 Gcc Countries: Ivd Reagents Market For Clinical Laboratories,

By Country, 2022–2029 (Usd Million)

Table 226 Ivd Reagents Market For Large Reference Laboratories,

By Region, 2022–2029 (Usd Million)

Table 227 North America: Ivd Reagents Market For Large Reference Laboratories,

By Country, 2022–2029 (Usd Million)

Table 228 Europe: Ivd Reagents Market For Large Reference Laboratories,

By Country, 2022–2029 (Usd Million)

Table 229 Asia Pacific: Ivd Reagents Market For Large Reference Laboratories,

By Country, 2022–2029 (Usd Million)

Table 230 Latin America: Ivd Reagents Market For Large Reference Laboratories,

By Country, 2022–2029 (Usd Million)

Table 231 Gcc Countries: Ivd Reagents Market For Large Reference Laboratories,

By Country, 2022–2029 (Usd Million)

Table 232 Ivd Reagents Market For Small & Medium Laboratories,

By Region, 2022–2029 (Usd Million)

Table 233 North America: Ivd Reagents Market For Small & Medium Laboratories,

By Country, 2022–2029 (Usd Million)

Table 234 Europe: Ivd Reagents Market For Small & Medium Laboratories,

By Country, 2022–2029 (Usd Million)

Table 235 Asia Pacific: Ivd Reagents Market For Small & Medium Laboratories,

By Country, 2022–2029 (Usd Million)

Table 236 Latin America: Ivd Reagents Market For Small & Medium Laboratories,

By Country, 2022–2029 (Usd Million)

Table 237 Gcc Countries: Ivd Reagents Market For Small & Medium Laboratories,

By Country, 2022–2029 (Usd Million)

Table 238 Ivd Reagents Market For Blood Banks, By Region, 2022–2029 (Usd Million)

Table 239 North America: Ivd Reagents Market For Blood Banks,

By Country, 2022–2029 (Usd Million)

Table 240 Europe: Ivd Reagents Market For Blood Banks,

By Country, 2022–2029 (Usd Million)

Table 241 Asia Pacific: Ivd Reagents Market For Blood Banks,

By Country, 2022–2029 (Usd Million)

Table 242 Latin America: Ivd Reagents Market For Blood Banks,

By Country, 2022–2029 (Usd Million)

Table 243 Gcc Countries: Ivd Reagents Market For Blood Banks,

By Country, 2022–2029 (Usd Million)

Table 244 Ivd Reagents Market For Home Care Settings,

By Region, 2022–2029 (Usd Million)

Table 245 North America: Ivd Reagents Market For Home Care Settings,

By Country, 2022–2029 (Usd Million)

Table 246 Europe: Ivd Reagents Market For Home Care Settings,

By Country, 2022–2029 (Usd Million)

Table 247 Asia Pacific: Ivd Reagents Market For Home Care Settings,

By Country, 2022–2029 (Usd Million)

Table 248 Latin America: Ivd Reagents Market For Home Care Settings,

By Country, 2022–2029 (Usd Million)

Table 249 Gcc Countries: Ivd Reagents Market For Home Care Settings,

By Country, 2022–2029 (Usd Million)

Table 250 Ivd Reagents Market For Pharmaceutical & Biotechnology Companies,

By Region, 2022–2029 (Usd Million)

Table 251 North America: Ivd Reagents Market For Pharmaceutical &

Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 252 Europe: Ivd Reagents Market For Pharmaceutical &

Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 253 Asia Pacific: Ivd Reagents Market For Pharmaceutical &

Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 254 Latin America: Ivd Reagents Market For Pharmaceutical &

Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 255 Gcc Countries: Ivd Reagents Market For Pharmaceutical &

Biotechnology Companies, By Country, 2022–2029 (Usd Million)

Table 256 Ivd Reagents Market For Academic Institutes,

By Region, 2022–2029 (Usd Million)

Table 257 North America: Ivd Reagents Market For Academic Institutes,

By Country, 2022–2029 (Usd Million)

Table 258 Europe: Ivd Reagents Market For Academic Institutes,

By Country, 2022–2029 (Usd Million)

Table 259 Asia Pacific: Ivd Reagents Market For Academic Institutes,

By Country, 2022–2029 (Usd Million)

Table 260 Latin America: Ivd Reagents Market For Academic Institutes,

By Country, 2022–2029 (Usd Million)

Table 261 Gcc Countries: Ivd Reagents Market For Academic Institutes,

By Country, 2022–2029 (Usd Million)

Table 262 Ivd Reagents Market For Other End Users, By Region,

2022–2029 (Usd Million)

Table 263 North America: Ivd Reagents Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 264 Europe: Ivd Reagents Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 265 Asia Pacific: Ivd Reagents Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 266 Latin America: Ivd Reagents Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 267 Gcc Countries: Ivd Reagents Market For Other End Users,

By Country, 2022–2029 (Usd Million)

Table 268 Ivd Reagents Market, By Region, 2022–2029 (Usd Million)

Table 269 Key Ivd Reagents Provided By Major Players In North America

Table 270 North America: Macroeconomic Indicators

Table 271 North America: Ivd Reagents Market, By Country, 2022–2029 (Usd Million)

Table 272 North America: Ivd Tests Conducted, By Country, 2022–2029 (Billion Unit)

Table 273 North America: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 274 North America: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 275 North America: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 276 North America: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 277 North America: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 278 North America: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 279 North America: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 280 Us: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 281 Us: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 282 Us: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 283 Us: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 284 Us: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 285 Us: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 286 Us: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 287 Canada: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 288 Canada: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 289 Canada: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 290 Canada: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 291 Canada: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 292 Canada: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 293 Canada: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 294 Key Ivd Reagents Provided By Major Players In Europe

Table 295 Europe: Macroeconomic Indicators

Table 296 Europe: Ivd Reagents Market, By Country, 2022–2029 (Usd Million)

Table 297 Europe: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 298 Europe: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 299 Europe: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 300 Europe: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 301 Europe: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 302 Europe: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 303 Europe: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 304 Germany: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 305 Germany: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 306 Germany: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 307 Germany: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 308 Germany: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 309 Germany: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 310 Germany: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 311 Uk: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 312 Uk: Antibodies Market, By Typ e, 2022–2029 (Usd Million)

Table 313 Uk: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 314 Uk: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 315 Uk: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 316 Uk: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 317 Uk: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 318 France: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 319 France: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 320 France: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 321 France: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 322 France: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 323 France: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 324 France: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 325 Italy: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 326 Italy: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 327 Italy: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 328 Italy: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 329 Italy: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 330 Italy: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 331 Italy: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 332 Spain: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 333 Spain: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 334 Spain: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 335 Spain: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 336 Spain: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 337 Spain: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 338 Spain: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 339 Rest Of Europe: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 340 Rest Of Europe: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 341 Rest Of Europe: Ivd Reagents Market, By Technology,

2022–2029 (Usd Million)

Table 342 Rest Of Europe: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 343 Rest Of Europe: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 344 Rest Of Europe: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 345 Rest Of Europe: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 346 Asia Pacific: Macroeconomic Indicators

Table 347 Asia Pacific: Ivd Reagents Market, By Country, 2022–2029 (Usd Million)

Table 348 Asia Pacific: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 349 Asia Pacific: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 350 Asia Pacific: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 351 Asia Pacific: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 352 Asia Pacific: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 353 Asia Pacific: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 354 Asia Pacific: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 355 Japan: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 356 Japan: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 357 Japan: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 358 Japan: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 359 Japan: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 360 Japan: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 361 Japan: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 362 China: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 363 China: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 364 China: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 365 China: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 366 China: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 367 China: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 368 China: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 369 India: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 370 India: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 371 India: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 372 India: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 373 India: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 374 India: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 375 India: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 376 Rest Of Asia Pacific: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 377 Rest Of Asia Pacific: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 378 Rest Of Asia Pacific: Ivd Reagents Market,

By Technology, 2022–2029 (Usd Million)

Table 379 Rest Of Asia Pacific: Ivd Reagents Market,

By Application, 2022–2029 (Usd Million)

Table 380 Rest Of Asia Pacific: Ivd Reagents Market,

By Test Type, 2022–2029 (Usd Million)

Table 381 Rest Of Asia Pacific: Ivd Reagents Market,

By End User, 2022–2029 (Usd Million)

Table 382 Rest Of Asia Pacific: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 383 Latin America: Macroeconomic Indicators

Table 384 Latin America: Ivd Reagents Market, By Country, 2022–2029 (Usd Million)

Table 385 Latin America: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 386 Latin America: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 387 Latin America: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 388 Latin America: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 389 Latin America: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 390 Latin America: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 391 Latin America: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 392 Brazil: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 393 Brazil: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 394 Brazil: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 395 Brazil: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 396 Brazil: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 397 Brazil: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 398 Brazil: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 399 Mexico: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 400 Mexico: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 401 Mexico: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 402 Mexico: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 403 Mexico: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 404 Mexico: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 405 Mexico: Clinical Laboratories Market, By Type, 2022–2029 (Usd Million)

Table 406 Rest Of Latin America: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 407 Rest Of Latin America: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 408 Rest Of Latin America: Ivd Reagents Market,

By Technology, 2022–2029 (Usd Million)

Table 409 Rest Of Latin America: Ivd Reagents Market,

By Application, 2022–2029 (Usd Million)

Table 410 Rest Of Latin America: Ivd Reagents Market,

By Test Type, 2022–2029 (Usd Million)

Table 411 Rest Of Latin America: Ivd Reagents Market,

By End User, 2022–2029 (Usd Million)

Table 412 Rest Of Latin America: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 413 Middle East & Africa: Macroeconomic Indicators

Table 414 Middle East & Africa: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 415 Middle East & Africa: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 416 Middle East & Africa: Ivd Reagents Market,

By Technology, 2022–2029 (Usd Million)

Table 417 Middle East & Africa: Ivd Reagents Market,

By Application, 2022–2029 (Usd Million)

Table 418 Middle East & Africa: Ivd Reagents Market,

By Test Type, 2022–2029 (Usd Million)

Table 419 Middle East & Africa: Ivd Reagents Market,

By End User, 2022–2029 (Usd Million)

Table 420 Middle East & Africa: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 421 Gcc Countries: Macroeconomic Indicators

Table 422 Gcc Countries: Ivd Reagents Market, By Country, 2022–2029 (Usd Million)

Table 423 Gcc Countries: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 424 Gcc Countries: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 425 Gcc Countries: Ivd Reagents Market, By Technology, 2022–2029 (Usd Million)

Table 426 Gcc Countries: Ivd Reagents Market, By Application, 2022–2029 (Usd Million)

Table 427 Gcc Countries: Ivd Reagents Market, By Test Type, 2022–2029 (Usd Million)

Table 428 Gcc Countries: Ivd Reagents Market, By End User, 2022–2029 (Usd Million)

Table 429 Gcc Countries: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 430 Kingdom Of Saudi Arabia: Ivd Reagents Market,

By Type, 2022–2029 (Usd Million)

Table 431 Kingdom Of Saudi Arabia: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 432 Kingdom Of Saudi Arabia: Ivd Reagents Market,

By Technology, 2022–2029 (Usd Million)

Table 433 Kingdom Of Saudi Arabia: Ivd Reagents Market,

By Application, 2022–2029 (Usd Million)

Table 434 Kingdom Of Saudi Arabia: Ivd Reagents Market,

By Test Type, 2022–2029 (Usd Million)

Table 435 Kingdom Of Saudi Arabia: Ivd Reagents Market,

By End User, 2022–2029 (Usd Million)

Table 436 Kingdom Of Saudi Arabia: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 437 United Arab Emirates: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 438 United Arab Emirates: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 439 United Arab Emirates: Ivd Reagents Market,

By Technology, 2022–2029 (Usd Million)

Table 440 United Arab Emirates: Ivd Reagents Market,

By Application, 2022–2029 (Usd Million)

Table 441 United Arab Emirates: Ivd Reagents Market,

By Test Type, 2022–2029 (Usd Million)

Table 442 United Arab Emirates: Ivd Reagents Market,

By End User, 2022–2029 (Usd Million)

Table 443 United Arab Emirates: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 444 Other Gcc Countries: Ivd Reagents Market, By Type, 2022–2029 (Usd Million)

Table 445 Other Gcc Countries: Antibodies Market, By Type, 2022–2029 (Usd Million)

Table 446 Other Gcc Countries: Ivd Reagents Market,

By Technology, 2022–2029 (Usd Million)

Table 447 Other Gcc Countries: Ivd Reagents Market,

By Application, 2022–2029 (Usd Million)

Table 448 Other Gcc Countries: Ivd Reagents Market,

By Test Type, 2022–2029 (Usd Million)

Table 449 Other Gcc Countries: Ivd Reagents Market,

By End User, 2022–2029 (Usd Million)

Table 450 Other Gcc Countries: Clinical Laboratories Market,

By Type, 2022–2029 (Usd Million)

Table 451 Overview Of Strategies Adopted By Key Players In Ivd Reagents

Market, 2021–2023

Table 452 Ivd Reagents Market: Degree Of Competition

Table 453 Ivd Reagents Market: Technology Footprint

Table 454 Ivd Reagents Market: Application Footprint

Table 455 Ivd Reagents Market: Test Type Footprint

Table 456 Ivd Reagents Market: Region Footprint

Table 457 Ivd Reagents Market: Detailed List Of Key Startups/Smes

Table 458 Ivd Reagents Market: Competitive Benchmarking Of Key Startups/Smes

Table 459 Ivd Reagents Market: Product Launches And Approvals,

January 2021–september 2024

Table 460 Ivd Reagents Market: Deals, January 2021–september 2024

Table 461 Ivd Reagents Market: Expansions, January 2021–september 2024

Table 462 Ivd Reagents Market: Other Developments, January 2021–september 2024

Table 463 Danaher Corporation: Company Overview

Table 464 Danaher Corporation: Products Offered

Table 465 Danaher Corporation: Deals, January 2021–september 2024

Table 466 Danaher Corporation: Expansions, January 2021–september 2024

Table 467 Danaher Corporation: Other Developments, January 2021–september 2024

Table 468 F. Hoffmann-la Roche Ltd.: Company Overview

Table 469 F. Hoffmann-la Roche Ltd.: Products Offered

Table 470 F. Hoffmann-la Roche Ltd.: Deals, January 2021–september 2024

Table 471 Abbott: Company Overview

Table 472 Abbott: Products Offered

Table 473 Abbott: Deals, January 2021–september 2024

Table 474 Siemens Healthineers Ag: Company Overview

Table 475 Siemens Healthineers Ag: Products Offered

Table 476 Siemens Healthineers Ag: Deals, January 2021–september 2024

Table 477 Thermo Fisher Scientific Inc.: Company Overview

Table 478 Thermo Fisher Scientific Inc.: Products Offered

Table 479 Thermo Fisher Scientific Inc.: Deals, January 2021–september 2024

Table 480 Thermo Fisher Scientific Inc.: Expansions, January 2021–september 2024

Table 481 Illumina, Inc.: Company Overview

Table 482 Illumina, Inc.: Products Offered

Table 483 Illumina, Inc.: Deals, January 2021–september 2024

Table 484 Biomérieux: Company Overview

Table 485 Biomérieux: Products Offered

Table 486 Biomérieux: Deals, January 2021–september 2024

Table 487 Bd: Company Overview

Table 488 Bd: Products Offered

Table 489 Bd: Deals, January 2021–september 2024

Table 490 Hologic, Inc.: Company Overview

Table 491 Hologic, Inc.: Products Offered

Table 492 Hologic, Inc.: Product Launches And Approvals,

January 2021–september 2024

Table 493 Hologic, Inc.: Deals, January 2021–september 2024

Table 494 Bio-rad Laboratories, Inc.: Company Overview

Table 495 Bio-rad Laboratories, Inc.: Products Offered

Table 496 Bio-rad Laboratories, Inc.: Deals, January 2021–september 2024

Table 497 Sysmex Corporation: Company Overview

Table 498 Sysmex Corporation: Products Offered

Table 499 Sysmex Corporation: Product Launches And Approvals,

January 2021–september 2024

Table 500 Sysmex Corporation: Deals, January 2021–september 2024

Table 501 Sysmex Corporation: Expansions, January 2021–september 2024

Table 502 Qiagen N.V.: Company Overview

Table 503 Qiagen N.V.: Products Offered

Table 504 Qiagen N.V.: Deals, January 2021–september 2024

Table 505 Agilent Technologies, Inc.: Company Overview

Table 506 Agilent Technologies, Inc.: Products Offered

Table 507 Agilent Technologies, Inc.: Deals, January 2021–september 2024

Table 508 Agilent Technologies, Inc.: Expansions, January 2021–september 2024

Table 509 Revvity: Company Overview

Table 510 Revvity: Products Offered

Table 511 Revvity: Deals, January 2021–september 2024

Table 512 Revvity: Other Developments, January 2021–september 2024

Table 513 Diasorin S.P.A.: Company Overview

Table 514 Diasorin S.P.A.: Products Offered

Table 515 Diasorin S.P.A.: Deals, January 2021–september 2024

Table 516 Grifols S.A.: Company Overview

Table 517 Grifols S.A.: Products Offered

Table 518 Grifols S.A.: Deals, January 2021–september 2024

Table 519 Werfen, S.A.: Company Overview

Table 520 Werfen, S.A.: Products Offered

Table 521 Werfen, S.A.: Deals, January 2021–september 2024

Table 522 Quidelortho Corporation: Company Overview

Table 523 Quidelortho Corporation: Products Offered

Table 524 Quidelortho Corporation: Deals, January 2021–september 2024

Table 525 Quidelortho Corporation: Expansions, January 2021–september 2024

Table 526 Chembio Diagnostics, Inc.: Company Overview

Table 527 Chembio Diagnostics, Inc.: Products Offered

Table 528 Surmodics, Inc.: Company Overview

Table 529 Surmodics, Inc.: Products Offered

Table 530 Merck Kgaa: Company Overview

Table 531 Merck Kgaa: Products Offered

Table 532 Medical & Biological Laboratories Co., Ltd.: Company Overview

Table 533 Canvax: Company Overview

Table 534 Prestige Diagnostics: Company Overview

Table 535 Adaltis S.R.L.: Company Overview

Table 536 Randox Laboratories Ltd.: Company Overview

Figures List

Figure 1 Ivd Reagents Market Segmentation And Regional Scope

Figure 2 Ivd Reagents Market: Research Design

Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region

Figure 4 Bottom-up Approach: Company Revenue Estimation Approach

Figure 5 Cagr Projections: Supply-side Analysis

Figure 6 Ivd Reagents Market: Top-down Approach

Figure 7 Data Triangulation Methodology

Figure 8 Ivd Reagents Market, By Type, 2024–2029 (Usd Million)

Figure 9 Ivd Reagents Market, By Technology, 2024–2029 (Usd Million)

Figure 10 Ivd Reagents Market, By Application, 2024–2029 (Usd Million)

Figure 11 Ivd Reagents Market, By Test Type, 2024–2029 (Usd Million)

Figure 12 Ivd Reagents Market, By End User, 2024–2029 (Usd Million)

Figure 13 Ivd Reagents Market, By Region, 2024–2029 (Usd Million)

Figure 14 Increasing Prevalence Of Chronic And Infectious Diseases To Drive Market

Figure 15 China To Lead Market During Forecast Period

Figure 16 Us And Laboratory Tests Segment Accounted For Largest Share Of

North American Ivd Reagents Market In 2023

Figure 17 China To Grow At Highest Cagr During Forecast Period

Figure 18 Ivd Reagents Market: Drivers, Restraints, Opportunities, And Challenges

Figure 19 Critical Impact Areas Of Ivd Reagents

Figure 20 Trends/Disruptions Impacting Customers’ Businesses

Figure 21 Ivd Reagents Market: Value Chain Analysis

Figure 22 Ivd Reagents Market: Supply Chain Analysis

Figure 23 Ivd Reagents Market: Ecosystem Analysis

Figure 24 Ivd Reagents Market: Investment And Funding Scenario, 2019−2024

Figure 25 Ivd Reagents Market: Patent Analysis, January 2014–march 2024

Figure 26 Ivd Reagents Market: Porter’s Five Forces Analysis

Figure 27 Influence Of Stakeholders On Buying Process Of Ivd Reagents, By End User

Figure 28 Key Buying Criteria For Ivd Reagents, By End User

Figure 29 North America: Ivd Reagents Market Snapshot

Figure 30 Asia Pacific: Ivd Reagents Market Snapshot

Figure 31 Ivd Reagents Market: Revenue Analysis Of Key Players,

2021–2023 (Usd Million)

Figure 32 Ivd Reagents Market Share Analysis Of Key Players, 2023

Figure 33 Financial Metrics

Figure 34 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of

Key Vendors, (2021–2023)

 

Figure 35 Ivd Reagents Market: Brand/Product Comparison

Figure 36 Ivd Reagents Market: Company Evaluation Matrix (Key Players), 2023

Figure 37 Ivd Reagents Market: Company Footprint

Figure 38 Ivd Reagents Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 39 Danaher Corporation: Company Snapshot (2023)

Figure 40 F. Hoffmann-la Roche Ltd.: Company Snapshot (2023)

Figure 41 Abbott: Company Snapshot (2023)

Figure 42 Siemens Healthineers Ag: Company Snapshot (2023)

Figure 43 Thermo Fisher Scientific Inc.: Company Snapshot (2023)

Figure 44 Illumina, Inc.: Company Snapshot (2023)

Figure 45 Biomérieux: Company Snapshot (2023)

Figure 46 Bd: Company Snapshot (2023)

Figure 47 Hologic, Inc.: Company Snapshot (2023)

Figure 48 Bio-rad Laboratories, Inc.: Company Snapshot (2023)

Figure 49 Sysmex Corporation: Company Snapshot (2022)

Figure 50 Qiagen N.V.: Company Snapshot (2023)

Figure 51 Agilent Technologies, Inc.: Company Snapshot (2023)

Figure 52 Revvity: Company Snapshot (2023)

Figure 53 Diasorin S.P.A.: Company Snapshot (2023)

Figure 54 Grifols S.A.: Company Snapshot (2023)

Figure 55 Werfen, S.A.: Company Snapshot (2023)

Figure 56 Quidelortho Corporation: Company Snapshot (2023)

Figure 57 Chembio Diagnostics, Inc.: Company Snapshot (2022)

Figure 58 Surmodics, Inc.: Company Snapshot (2023)

Figure 59 Merck Kgaa: Company Snapshot (2023)